Cladribine in indolent non-Hodgkin's lymphoma. - Wikidata - wikimedia - TriplyDB

Cladribine in indolent non-Hodgkin's lymphoma.

Cladribine in indolent non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q37134422

about

Cladribine in indolent non-Hodgkin's lymphoma.

http://www.wikidata.org/entity/Q37134422

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cladribine in indolent non-Hodgkin's lymphoma.

@en

Cladribine in indolent non-Hodgkin's lymphoma.

@nl

type

label

Cladribine in indolent non-Hodgkin's lymphoma.

@en

Cladribine in indolent non-Hodgkin's lymphoma.

@nl

prefLabel

Cladribine in indolent non-Hodgkin's lymphoma.

@en

Cladribine in indolent non-Hodgkin's lymphoma.

@nl

P1433

Q37134422-5955A9B8-E015-451A-AD8F-810E353FAAED

P1476

Q37134422-760528C9-6938-4EE3-A9D4-FE3DF390EC4B

P2093

Q37134422-5527C151-84DE-4188-860E-AC157F432A4E

Q37134422-DA802AB6-BEB1-46BB-9120-4B886CA1DB98

P2860

Q37134422-04072BFB-7271-45C9-9885-6F9597E8FC1A

Q37134422-04676D4A-661B-4928-B81C-24CF3786309E

Q37134422-096BB38C-4C9D-4AFD-B073-629A3522E07D

Q37134422-114B44B3-D5FA-4375-97D5-6D7A9A626868

Q37134422-19C16B6E-0B69-4583-A6FC-2BADB3A9D38F

Q37134422-1BF1808E-BEB8-401E-884B-4FF131B4FDBA

Q37134422-1E800608-5748-473E-AD60-84B351F2219E

Q37134422-2283C8E4-3EF3-4186-98FF-C1F26264DE7C

Q37134422-263EAF62-DED3-4B33-9C58-11EE2D759B58

Q37134422-34494EF4-2C7F-4884-BF99-0706F9E0EA6C

P304

Q37134422-C88AD65C-159E-4670-9928-C7499B673588

P31

Q37134422-1BE7C0F4-3C47-4722-94C1-D002314778B4

P356

Q37134422-0129875D-AC01-4146-9995-D8A064BB4DE4

P433

Q37134422-8ABBEDFF-C622-4290-B5FD-D960017DC63C

P478

Q37134422-1A65F7BE-4CC9-43D2-B714-219B686C1CA0

P577

Q37134422-A431EBE0-6C22-4D36-A656-3007F135DAA0

P5875

Q37134422-292DB2DB-2494-4309-96F4-126164A04FD3

P698

Q37134422-D960C40E-819E-45E8-B349-3B05754170B0

P356

14737140.8.4.535

P1433

Expert Review of Anticancer Therapy

P1476

Cladribine in indolent non-Hodgkin's lymphoma.

@en

P2093

Alan Saven

http://www.w3.org/2001/XMLSchema#string

Darren S Sigal

http://www.w3.org/2001/XMLSchema#string

P2860

Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease

Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo

Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c

Cancer statistics, 2007

Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse.

2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.

Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study.

Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma.

2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia.

2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignancies.

P304

535-545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.8.4.535

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5449236

http://www.w3.org/2001/XMLSchema#string

P698

18402520

http://www.w3.org/2001/XMLSchema#string